Literature DB >> 34205301

Antibody Response Following a Two-Dose mRNA Vaccination Regimen, in Health Care Workers of a Tertiary Hospital in Athens, Greece.

Elissavet Kontou1, Kyriaki Ranellou2, Dimitrios Zoulas3, Anastasia Bletsa1, Eirini Rompola4, Evangelia-Theophano Piperaki5, Nikolaos Athanasiou6, Kleio Ampelakiotou1, Maria Pratikaki4, Christina Stergiopoulou3, Athina Argyropoulou2, Androula Alevra4, Aggeliki Megalou3, Alexandra Tsirogianni1.   

Abstract

We analyzed the antibody responses of 564 hospital workers in Athens, Greece, after vaccination with two doses of the BNT162b2 (Comirnaty®; BioNTech and Pfizer) mRNA COVID-19 vaccine. A greater antibody increase was observed in women, younger age groups, previously infected individuals and personnel working in COVID-19 clinics. Notably, individuals with a prior COVID-19 infection mounted a significantly higher antibody titer following the first dose than the rest of the population; the same was true for those working in COVID-19 clinics, even without history of previous infection.

Entities:  

Keywords:  SARS CoV-2; antibody response; healthcare workers; mRNA vaccine

Year:  2021        PMID： 34205301     DOI： 10.3390/jpm11060576

Source DB:  PubMed          Journal:  J Pers Med        ISSN： 2075-4426


  8 in total

1.  Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis.

Authors:  Matías J Pereson; Lucas Amaya; Karin Neukam; Patricia Baré; Natalia Echegoyen; María Noel Badano; Alicia Lucero; Antonella Martelli; Gabriel H Garcia; Cristina Videla; Alfredo P Martínez; Federico A Di Lello
Journal:  Clin Microbiol Infect       Date:  2022-05-17       Impact factor: 13.310

2.  Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.

Authors:  Éva Anna Piros; Orsolya Cseprekál; Anna Görög; Bernadett Hidvégi; Márta Medvecz; Zsófia Szabó; Ferenc Olajos; Eszter Barabás; Noémi Galajda; Pál Miheller; Péter Holló
Journal:  Dermatol Ther       Date:  2022-03-05       Impact factor: 3.858

3.  Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions.

Authors:  Sang Won Lee; Ji-Yong Moon; Sun-Kyung Lee; Hyun Lee; SeolHwa Moon; Sung Jun Chung; Yoomi Yeo; Tai Sun Park; Dong Won Park; Tae-Hyung Kim; Jang Won Sohn; Ho Joo Yoon; Sang-Heon Kim
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

4.  Antibody Response Induced by BNT162b2 and mRNA-1273 Vaccines against the SARS-CoV-2 in a Cohort of Healthcare Workers.

Authors:  Juan F Delgado; Antoni Berenguer-Llergo; Germà Julià; Gema Navarro; Mateu Espasa; Sara Rodríguez; Noemí Sánchez; Eva Van Den Eynde; Marta Navarro; Joan Calvet; Jordi Gratacós; Rosa M Serrano; Pilar Peña; María J Amengual
Journal:  Viruses       Date:  2022-06-07       Impact factor: 5.818

5.  Examining the association between vaccine reactogenicity and antibody titer dynamics after the third dose of BNT162b2 vaccine using a mixed-effects model.

Authors:  Naomi Matsumoto; Hideharu Hagiya; Masanori Nakayama; Masanori Furukawa; Toshiharu Mitsuhashi; Soshi Takao; Fumio Otsuka; Takashi Yorifuji
Journal:  J Infect Chemother       Date:  2022-09-19       Impact factor: 2.065

Review 6.  Viral vector and nucleic acid vaccines against COVID-19: A narrative review.

Authors:  Saeed Khoshnood; Roya Ghanavati; Maryam Shirani; Hossein Ghahramanpour; Mohammad Sholeh; Aref Shariati; Nourkhoda Sadeghifard; Mohsen Heidary
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

7.  Association of sleep duration and quality with immunological response after vaccination against severe acute respiratory syndrome coronavirus-2 infection.

Authors:  Nikolaos Athanasiou; Katerina Baou; Eleni Papandreou; Georgia Varsou; Anastasia Amfilochiou; Elisavet Kontou; Athanasia Pataka; Konstantinos Porpodis; Ioanna Tsiouprou; Evangelos Kaimakamis; Serafeim-Chrysovalantis Kotoulas; Evgenia Katsibourlia; Christina Alexopoulou; Izolde Bouloukaki; Meropi Panagiotarakou; Aspasia Dermitzaki; Nikolaos Charokopos; Kyriakh Pagdatoglou; Kallirroi Lamprou; Sofia Pouriki; Foteini Chatzivasiloglou; Zoi Nouvaki; Alexandra Tsirogianni; Ioannis Kalomenidis; Paraskevi Katsaounou; Emmanouil Vagiakis
Journal:  J Sleep Res       Date:  2022-06-07       Impact factor: 5.296

8.  Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers.

Authors:  Cristina Costa; Enrica Migliore; Claudia Galassi; Gitana Scozzari; Giovannino Ciccone; Maurizio Coggiola; Enrico Pira; Antonio Scarmozzino; Giovanni La Valle; Paola Cassoni; Rossana Cavallo
Journal:  Vaccines (Basel)       Date:  2022-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.